Table 7_2

You Are Here: AHRQ Home > Quality & Patient Safety > Measuring Healthcare Quality > National Healthcare Quality & Disparities Reports, 2008 > Data Tables Appendix

Table 7_2_1.2a
People age 12 and over who needed treatment for illicit drug use and who received such treatment at a specialty facility in the last 12 months,^a by race, United States, 2006
Population group		Total		Single race										Multiple races
		Total		White		Black		Asian		NHOPI		AI/AN		Multiple races
		Percent	SE	Percent	SE	Percent	SE	Percent	SE	Percent	SE	Percent	SE	Percent	SE
Total		20.3	1.4	19.6	1.5	25.8	3.9	*	*	*	*	*	*	*	*
Age	12–17	11.2	1.4	12.2	1.6	2.2	1.0	*	*	*	*	*	*	*	*
	18–44	20.0	1.5	20.3	1.7	21.7	3.9	*	*	*	*	*	*	*	*
	45–64	*	*	*	*	*	*	*	*	*	*	*	*	*	*
	65 and over	*	*	*	*	*	*	*	*	*	*	*	*	*	*
Gender	Male	19.8	1.9	17.9	2.1	27.8	5.2	*	*	*	*	*	*	*	*
Gender	Female	21.3	2.0	22.6	2.3	*	*	*	*	*	*	*	*	*	*
Education, age 18 and over	Less than high school	31.7	3.3	29.4	3.8	*	*	*	*	*	*	*	*	*	*
	High school graduate	21.9	2.5	24.0	3.0	*	*	*	*	*	*	*	*	*	*
	At least some college	15.9	2.8	13.9	2.7	*	*	*	*	*	*	*	*	*	*
County type	MSA	19.7	1.6	18.5	1.7	27.0	4.1	*	*	*	*	*	*	*	*
County type	Non-MSA	24.1	2.8	25.7	3.2	*	*	*	*	*	*	*	*	*	*

^a Received any illicit drug treatment at a specialty facility refers to treatment received at a hospital (inpatient), a rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop drug use, or for medical problems associated with drug use. Respondents were classified as needing treatment for an illicit drug problem if they met at least one of three criteria during the past year: (1), dependent on any illicit drug; (2), abuse of any illicit drug; or (3), received treatment for an illicit drug problem at a specialty facility, i.e., drug and alcohol rehabilitation facilities (inpatient or outpatient), hospitals (inpatient only), and mental health centers. Illicit drugs include marijuana/hashish, cocaine (including crack), inhalants, hallucinogens, heroin, or prescription-type psychotherapeutic medications (nonmedical use).

* - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Key: AI/AN: American Indian or Alaska Native; NHOPI: Native Hawaiian or Other Pacific Islander; MSA: metropolitan statistical area; SE: standard error.

Source: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, National Survey on Drug Use and Health.